Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS® technology
Nanoform Finland Plc | Company Release | May 20, 2025…
INSIDE INFORMATION MADE PUBLIC: NANOFORM PARTNERS WITH TWO SPECIALIST HEALTHCARE INVESTORS TO DEVELOP AND COMMERCIALISE NANOENCORAFENIB
Nanoform Finland Plc | Inside Information | May 20, 2025…
Invitation to Nanoform’s Q1 2025 Report Presentation
Nanoform Finland Plc | Press Release | May 06, 2025…
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Company release Nanoform Finland Plc April 15, 2025 14.10 Finnish…
Resolutions of Nanoform Finland Plc’s Annual General Meeting on April 15, 2025
Company release Nanoform Finland Plc April 15, 2025 14.00 Finnish…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc
Notice to the Annual General Meeting of NANOFORM FINLAND Plc…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen Nanoform Finland Oyj:n (”Yhtiö”)…
Nanoform 2024 report: Deal discussions around product kernels intensify
Company Announcement Nanoform Finland Plc February 27, 2025 08:10 a.m.…
Invitation to Nanoform’s Q4 and FY 2024 Report Presentation
Press release Nanoform Finland Plc February 13, 2025 11:00 a.m.…